3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Carcinoma, Hepatocellular
6
Breast Neoplasms
4
Esophageal Squamous Cell Carcinoma
3
Uterine Cervical Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Pancreatic Neoplasms
2
Locally Advanced Gastric Cancer
2
Colorectal Neoplasms
2
Cervical Cancer Metastatic
2
Triple Negative Breast Neoplasms
1
Sarcoma
1
Rectal Neoplasms
1
Rectal Cancer Patients
1
Rare Tumour
1
Non-squamous Non-small Cell Lung Cancer
1
Nasopharyngeal Carcinoma
1
Mouth Neoplasms
1
Lung Neoplasms
1
Liver Neoplasms
1
Liposarcoma
1
Laryngeal Neoplasms
1
Esophageal Squamour Cell Cancer
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Biliary Tract Neoplasms
1
Advanced Triple Negative Breast Cancer
1
Advanced Pancreatic Cancer
1
Interventions
lenvatinib
1
camrelizumab
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Advanced Triple Negative Breast Cancer
×
camrelizumab
×
Clear all
NCT06849492
2025-02-27
SHIFT-001
Fudan University
Phase 2
Not yet recruiting
120 enrolled